184 related articles for article (PubMed ID: 4931500)
1. The role of immunosuppression in the genesis and growth of malignant tumours.
Reis HE
Ger Med Mon; 1971; 1(1):16-21. PubMed ID: 4931500
[No Abstract] [Full Text] [Related]
2. [Significance of immunosuppression for the origin and growth of malignant tumors].
Reis HE
Dtsch Med Wochenschr; 1971 Jan; 96(4):170-4. PubMed ID: 4992740
[No Abstract] [Full Text] [Related]
3. Immunology in neoplasia relating to diagnosis, therapy and transplantation. Immunosuppression and oncogenesis.
Cerilli J; Hattan D
Am J Clin Pathol; 1974 Aug; 62(2):218-23. PubMed ID: 4602088
[No Abstract] [Full Text] [Related]
4. Immunosuppression and neoplasia. I. A critical review of experimental carcinogenesis and the immunesurveillance theory.
Gleichmann H; Gleichmann E
Klin Wochenschr; 1973 Mar; 51(6):255-9 contd. PubMed ID: 4147391
[No Abstract] [Full Text] [Related]
5. Tumour development following immunosuppression.
Allison AC
Proc R Soc Med; 1970 Oct; 63(10):1077-80. PubMed ID: 4320709
[No Abstract] [Full Text] [Related]
6. Immunodepression and malignancy.
Stutman O
Adv Cancer Res; 1975; 22():261-422. PubMed ID: 766581
[No Abstract] [Full Text] [Related]
7. Immunosuppression and neoplasia.
Balner H
Rev Eur Etud Clin Biol; 1970; 15(6):599-604. PubMed ID: 4919177
[No Abstract] [Full Text] [Related]
8. Transplantation antigens and viral carcinogenesis.
Haughton G; Nash DR
Prog Med Virol; 1969; 11():248-306. PubMed ID: 4906871
[No Abstract] [Full Text] [Related]
9. Malignancy as a complication of immunosuppressive therapy.
Leibowitz S; Schwartz RS
Adv Intern Med; 1971; 17():95-123. PubMed ID: 4145004
[No Abstract] [Full Text] [Related]
10. Immunosuppression and cancer.
Smithers DW; Field EO
Lancet; 1969 Mar; 1(7596):672. PubMed ID: 4179900
[No Abstract] [Full Text] [Related]
11. [Immunosuppression mechanism affecting the development of neoplasms].
Rupniewska ZM; Kurowska M
Pol Tyg Lek; 1980 Mar; 35(12):455-7. PubMed ID: 6966796
[No Abstract] [Full Text] [Related]
12. Immunosuppressive chemotherapy and malignancy.
Schwartz RS
Transplant Proc; 1974 Dec; 6(4 Suppl 1):45-8. PubMed ID: 4612903
[No Abstract] [Full Text] [Related]
13. [Chronic antigenic stimulation as a pathogenic factor in the development of malignant lymphoma].
Myking AO
Nord Med; 1971 May; 85(21):645-9. PubMed ID: 5581410
[No Abstract] [Full Text] [Related]
14. Complications of immunosuppression.
Penn I
Minerva Chir; 1971 Jul; 26(13):718-20. PubMed ID: 5567243
[No Abstract] [Full Text] [Related]
15. Immunosuppression and neoplasia. II. Is deficient immunesurveillance the only mechanism by which immunosuppression promotes neoplasia? A speculative review.
Gleichmann E; Gleichmann H
Klin Wochenschr; 1973 Mar; 51(6):260-5 concl. PubMed ID: 4144595
[No Abstract] [Full Text] [Related]
16. [Immunosuppression, genesis and growth of malignant tumours].
Reis HE
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972; 78(1):42-50. PubMed ID: 4264377
[No Abstract] [Full Text] [Related]
17. [Immunosuppression by means of antilymphocyte serums in humans].
Revillard JP
Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
[No Abstract] [Full Text] [Related]
18. Another look at immunologic surveillance.
Schwartz RS
N Engl J Med; 1975 Jul; 293(4):181-4. PubMed ID: 1094290
[No Abstract] [Full Text] [Related]
19. [Oncornavirus, biological and immunological considerations].
Chieco-Bianchi G
G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):265-77. PubMed ID: 4125502
[No Abstract] [Full Text] [Related]
20. Immunosuppression and its complications.
Woodruff M
Proc R Soc Med; 1969 Apr; 62(4):411-6. PubMed ID: 4897833
[No Abstract] [Full Text] [Related]
[Next] [New Search]
